Suppression Colitis and Colitis-Associated Colon Cancer by Anti-S100a9 Antibody in Mice
Xuemei Zhang(Weifang Medical University), Jian Ma(Central South University), Xiang Zheng(Novo Nordisk Foundation), Lingyu Wei(East China University of Science and Technology), Yuanjun Lu(East China University of Science and Technology), Peishan Liu(Central South University), Siwen Wang(Dalian Jiaotong University), Zailong Qin(Guangxi Maternal and Child Health Hospital), Guiyuan Li(Xuzhou Medical College), Jing Wang(Wuhan University), Jia Wang(Umeå University), Peng Qiu(Central South University), Qiurong Ye(Central South University), Feiyan Ai(Central South University), Shourong Shen(Central South University)
Cited by 96
Related Papers
S100A8/A9 in Inflammation
|Frontiers in Immunology|2018|1.5k
Circular RNAs function as ceRNAs to regulate and control human cancer progression
|Molecular Cancer|2018|1.1k
Neoantigen vaccine: an emerging tumor immunotherapy
|Molecular Cancer|2019|718
Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics
|Molecular Therapy|2013|624
Regulatory mechanisms of PD-1/PD-L1 in cancers
|Molecular Cancer|2024|619